✨ Free AI Report
Affluent Medical SA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Affluent Medical SA
Company Research

Affluent Medical SA: Business Overview, Financials & Competitive Analysis

Affluent Medical SA scores 4/10 on the AskCyborg Cyborg Score (Mixed). Early-stage MedTech innovator executing strategic acquisitions but burning cash with uncertain pathway to commercialization profitability. The company has negative EBITDA of -13.52M EUR with EBITDA margin of -323.58%. Net income for the last half-year was -9.37M EUR, worsening from -5.37M EUR in the previous report. While facing profitability challenges.

What is Affluent Medical SA's industry? Affluent Medical SA operates in Medical Device Manufacturing - Minimally Invasive Implants & Prostheses. AskCyborg classifies Affluent Medical SA under Medical Device Manufacturing - Minimally Invasive Implants & Prostheses in its company registry.

Affluent Medical is a French MedTech company specialising in the international development and industrialisation of innovative clinical-stage medical prostheses for the treatment of urinary incontinence and mitral val...

4/ 10Mixed

Cyborg Score thesis

Early-stage MedTech innovator executing strategic acquisitions but burning cash with uncertain pathway to commercialization...

Read the full analyst-debate transcript →
Industry Medical Device Manufacturing - Minimally Invasive Implants & Prostheses
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Affluent Medical SA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Affluent Medical SA

AskCyborg analysts argue the bull and bear cases for Affluent Medical SA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Affluent Medical SA OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Affluent Medical SA Overview

Pro stress-test →

Affluent Medical is a French MedTech company specialising in the international development and industrialisation of innovative clinical-stage medical prostheses for the treatment of urinary incontinence and mitral valve pathology. The company develops innovative, next-generation, minimally invasive implants to restore critical physiological functions in cardiovascular and urological therapies.

Strategic Profile

Pro stress-test →

Founded by Truffle Capital, Affluent Medical aims to become a global benchmark player in the field of urology and interventional cardiology. The company recently became Carvolix and announced the finalisation of acquisitions of Caranx Medical and Artedrone, signaling a shift toward strategic consolidation to build comprehensive treatment portfolios.

Competitive Landscape

Pro stress-test →

The MedTech medtech device market for mitral valve and urinary incontinence solutions is dominated by established players like Edwards Lifesciences (Sapien), Abbott (MitraClip), and Boston Scientific. Affluent Medical competes as an innovative disruptor with minimally invasive approaches but lacks the commercial scale and regulatory approval of incumbents.

Industry Context

Affluent Medical SA operates in Medical Device Manufacturing - Minimally Invasive Implants & Prostheses.

Key facts

Founded: 2011 · Headquarters: Aix-en-Provence, France · Employees: 77 · Market cap: $47.4M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Affluent Medical SA.

  • The company's three medical devices are currently in the clinical phase with CE marking and launches expected soon in target markets
  • Recent acquisitions of Caranx Medical and Artedrone expand treatment capabilities and represent major strategic pivot
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2025Key appointments announced for Medical and Clinical affairs leadership
  • RecentCompany transitioned to Carvolix brand and completed acquisitions of Caranx Medical and Artedrone
  • +1 moreTrack every material event for Affluent Medical SA as it happens. Explore monitoring →
Get alerted when Affluent Medical SA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Sapien Transcatheter Heart ValveMarket leader in transcatheter heart valve replacement→MitraClipMitral valve repair device and market standard→Entellus Medical PortfolioMinimally invasive surgical solutions→

Compare Affluent Medical SA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Affluent Medical SA operates in Medical Device Manufacturing - Minimally Invasive Implants & Prostheses. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Device Manufacturing - Minimally Invasive Implants & Prostheses research →
NEW · MCP server

Ask your AI assistant about Affluent Medical SA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Affluent Medical SA and its top competitor on Cyborg Score”
“What did Affluent Medical SA do this quarter?”
“Is Affluent Medical SA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Affluent Medical SA do?+
Affluent Medical is a French MedTech company specialising in the international development and industrialisation of innovative clinical-stage medical prostheses for the treatment of urinary incontinence and mitral val...
What is Affluent Medical SA's Cyborg Score?+
Affluent Medical SA has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Affluent Medical SA's main competitors?+
Named competitors include Sapien Transcatheter Heart Valve, MitraClip, Entellus Medical Portfolio. The full competitive landscape is in the AskCyborg report.
How can I get the full Affluent Medical SA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Affluent Medical SA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Affluent Medical SA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.